![Biosensors | Free Full-Text | Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers Biosensors | Free Full-Text | Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers](https://pub.mdpi-res.com/biosensors/biosensors-13-00398/article_deploy/html/images/biosensors-13-00398-g005.png?1679128297)
Biosensors | Free Full-Text | Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers
![Biosensors | Free Full-Text | Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers Biosensors | Free Full-Text | Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers](https://pub.mdpi-res.com/biosensors/biosensors-13-00398/article_deploy/html/images/biosensors-13-00398-g001-550.jpg?1679128296)
Biosensors | Free Full-Text | Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers
![PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Table1-1.png)
PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
![Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Table3-1.png)
Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
![Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Table2-1.png)
Table 3 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
![PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/66b1cd66c5a66439bb3847578e78918661a4df89/4-Figure2-1.png)
PDF] Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
![Diagnostics | Free Full-Text | The Non-Cancer Specific Elevation of the Serum Squamous Cell Carcinoma Antigen during the Post-Radiotherapy Follow-Up of Cervical Cancer Patients Diagnostics | Free Full-Text | The Non-Cancer Specific Elevation of the Serum Squamous Cell Carcinoma Antigen during the Post-Radiotherapy Follow-Up of Cervical Cancer Patients](https://www.mdpi.com/diagnostics/diagnostics-11-01585/article_deploy/html/images/diagnostics-11-01585-g001.png)